Up-date on diagnostic strategies of invasive aspergillosis

Area of Science:

• Medical Mycology
• Infectious Diseases
• Diagnostic Microbiology

Background:

• Invasive fungal infections (IFIs) pose significant morbidity and mortality risks, particularly in immunosuppressed patients, with fatality rates up to 80% in neutropenic cases.
• Early and reliable diagnosis of IFIs is hindered by non-specific clinical symptoms and limitations of conventional diagnostic methods, which are often delayed.
• Current serological tests, such as galactomannan enzyme immunoassay for invasive aspergillosis, show promise but exhibit variable sensitivity and specificity.

Purpose of the Study:

• To review the current landscape of diagnosing invasive fungal infections, with a specific emphasis on Aspergillus-related infections.
• To evaluate the utility of established diagnostic techniques including culture, microscopy, imaging, and CT-guided biopsies.
• To discuss emerging molecular diagnostic techniques and their potential for routine clinical application.

Main Methods:

• Review of current literature on diagnostic methods for invasive fungal infections.
• Analysis of conventional diagnostic techniques (culture, microscopy, imaging, biopsy).
• Evaluation of serological assays (e.g., galactomannan enzyme immunoassay) and commercial kits (e.g., Platelia Aspergillus®, Fungitell®).
• Discussion of novel molecular techniques such as polymerase chain reaction (PCR)-based assays, rolling circle amplification (RCA), loop-mediated amplification (LAMP), and nucleic acid sequence-based amplification (NASBA).

Main Results:

• Conventional methods for diagnosing invasive fungal infections are often slow and lack sensitivity.
• Serological tests offer improved diagnostic capabilities but require careful interpretation due to variable performance.
• Molecular techniques under development show significant potential for rapid and accurate diagnosis of Aspergillus infections.

Conclusions:

• Accurate and timely diagnosis of invasive fungal infections remains a critical challenge in immunosuppressed patients.
• A combination of conventional and advanced diagnostic methods, including emerging molecular techniques, is essential for optimal patient management.
• Future research should focus on validating and integrating novel molecular assays into routine diagnostic workflows for improved outcomes in invasive aspergillosis.